We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $254M
1-Year Est. Return 426.76%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+426.76%
3 Year Est. Return
+1,102.13%
5 Year Est. Return
+979.15%
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$13.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAZE
1
Maze Therapeutics
MAZE
$1.33B
$134M 52.63%
4,473,958
– –
TNGX icon
2
Tango Therapeutics
TNGX
$3.94B
$120M 47.37%
6,374,574
– –

Similar funds

OPWM
Oxinas Partners Wealth Management Jeffersonville, Indiana $254M AUM 31.6% 1-Year Est. Return
SRCM
Signature Resources Capital Management Newport Beach, California $254M AUM 26.72% 1-Year Est. Return
SOAG
Silver Oak Advisory Group Portland, Oregon $254M AUM 12.01% 1-Year Est. Return
MCM
McKinney Capital Management Houston, Texas $254M AUM
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $254M AUM 35.88% 1-Year Est. Return
GAM
GEM Asset Management Plymouth, Michigan $254M AUM 23.24% 1-Year Est. Return
AFO
Aurelius Family Office Bedford, New Hampshire $254M AUM 15.09% 1-Year Est. Return

TRV GP IV's Q2 2026 Portfolio in Review

As of Q2 2026, TRV GP IV held 2 positions worth $254M, down 5% from $267M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's ten largest holdings make up 100% of its $254M portfolio in Q2 2026.
  • TRV GP IV opened 0 new positions and closed 0 in Q2 2026.
  • TRV GP IV's portfolio value fell 5% quarter-over-quarter to $254M.

Based on TRV GP IV's 13F filing for Q2 2026, filed 10 Aug 2026.